HN2002000050A - PHARMACEUTICALLY ACTIVE COMPOUNDS - Google Patents

PHARMACEUTICALLY ACTIVE COMPOUNDS

Info

Publication number
HN2002000050A
HN2002000050A HN2002000050A HN2002000050A HN2002000050A HN 2002000050 A HN2002000050 A HN 2002000050A HN 2002000050 A HN2002000050 A HN 2002000050A HN 2002000050 A HN2002000050 A HN 2002000050A HN 2002000050 A HN2002000050 A HN 2002000050A
Authority
HN
Honduras
Prior art keywords
active compounds
pharmaceutically active
etil
useful
phosphodyphate
Prior art date
Application number
HN2002000050A
Other languages
Spanish (es)
Original Assignee
Inc Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inc Pfizer filed Critical Inc Pfizer
Publication of HN2002000050A publication Critical patent/HN2002000050A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS FARMACEUTICAMENTE UTILES Y EN PARTICULAR, A 5 (2-BUTOXI - 3 - (1 - HIDROXIETIL) - 3 - PIRIDINIL - 3 - ETIL - 2 - (1 - ETIL - - AZETIDINIL) - 2, 6 - DIHIDRO - 7H - PIRAZOLO (4, 3 - D) PIRIMIDIN 7 - ONA, QUE SSON UTILES EN LA INHIBICION DE LAS FOSFODIESTERASAS DE GUANOSINA 3', 5' - MONOFOSFATO CICLICO DE TIPO 5 (GMPc PDE5).THIS INVENTION REFERS TO PHARMACEUTICALLY USEFUL AND PARTICULAR COMPOUNDS, A 5 (2-BUTOXI - 3 - (1 - HYDROXYETHYL) - 3 - PIRIDINIL - 3 - ETIL - 2 - (1 - ETIL - - AZETIDINIL) - 2, 6 - DIHIDRO - 7H - PIRAZOLO (4, 3 - D) PIRIMIDIN 7 - ONA, WHICH ARE USEFUL IN THE INHIBITION OF GUANOSINE 3 ', 5' PHOSPHODIESTERASES - TYPE 5 CYCLIC PHOSPHODYPHATE (GMPc PDE5).

HN2002000050A 2001-03-09 2002-03-08 PHARMACEUTICALLY ACTIVE COMPOUNDS HN2002000050A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0105893.2A GB0105893D0 (en) 2001-03-09 2001-03-09 Pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
HN2002000050A true HN2002000050A (en) 2002-09-13

Family

ID=9910362

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000050A HN2002000050A (en) 2001-03-09 2002-03-08 PHARMACEUTICALLY ACTIVE COMPOUNDS

Country Status (8)

Country Link
AP (1) AP2002002462A0 (en)
GB (1) GB0105893D0 (en)
GT (1) GT200200044A (en)
HN (1) HN2002000050A (en)
PA (1) PA8541101A1 (en)
PE (1) PE20021153A1 (en)
TN (1) TNSN02023A1 (en)
WO (1) WO2002072586A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
JP2006511606A (en) 2002-12-13 2006-04-06 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー Α-2-δ ligand to treat lower urinary tract symptoms
MXPA06000623A (en) * 2003-07-16 2006-04-11 Pfizer Treatment of sexual dysfunction.
JP2009503020A (en) 2005-08-03 2009-01-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Use of flibanserin in the treatment of obesity
CA2626134C (en) 2005-10-29 2013-12-24 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
JP2009541443A (en) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Flibanserin for the treatment of urinary incontinence and related diseases
EA200900264A1 (en) 2006-08-14 2009-08-28 Бёрингер Ингельхайм Интернациональ Гмбх COMPOSITIONS OF FLIBANSERIN AND METHOD OF THEIR PREPARATION
AU2007287639A1 (en) 2006-08-25 2008-02-28 Boehringer Ingelheim International Gmbh Controlled release system and method for manufacturing the same
PE20091188A1 (en) 2007-09-12 2009-08-31 Boehringer Ingelheim Int COMPOUND 1- [2- (4- (3-TRIFLUOROMETIL-PHENYL) PIPERAZIN-1-IL) ETHYL] -2,3-DIHYDRO-1H-BENZIMIDAZOL-2-ONA (FLIBANSERIN), ITS ADDITION SALTS AND PHARMACEUTICAL COMPOSITIONS THAT THEY CONTAIN
CA2686480A1 (en) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1371647E (en) * 1998-04-20 2005-10-31 Pfizer PYRIDINE-3-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS INTERMEDIARIES
GB9823101D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
CZ20021151A3 (en) * 1999-10-11 2003-03-12 Pfizer Inc. 5-(2-substituted-5-heterocyclyl sulfonylpyrid-3-yl)-dihydropyrazolo[4,3-d]-pyrimidin-7-ones functioning as phosphodiesterase inhibitors
CO5271697A1 (en) * 2000-01-12 2003-04-30 Pfizer Prod Inc COMPOSITIONS AND PROCEDURES FOR THE TREATMENT OF AFFECTIONS THAT RESPOND TO AN INCREASE OF TESTOSTERONE

Also Published As

Publication number Publication date
TNSN02023A1 (en) 2005-12-23
GB0105893D0 (en) 2001-04-25
PE20021153A1 (en) 2002-12-17
PA8541101A1 (en) 2003-11-12
GT200200044A (en) 2002-12-02
AP2002002462A0 (en) 2002-06-30
WO2002072586A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
HN2004000538A (en) "PIRIDO [2,3-d] PYRIMIDINE-2,4-DIAMINES AS-INHIBITORS OF PDE 2"
DK1265889T3 (en) Drugs for viral diseases
DE60215157D1 (en) USES OF ANTIVIRAL NUCLEOSIDE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HEPATITIS C INFECTIONS
CR8416A (en) 5,7- DIAMINOPIRAZOLO [4,3-D] PYRIMIDINS WITH INHIBITING ACTIVITY OF THE PDE-5
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
HN2001000224A (en) IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI - INFLAMMATORY AND ANALGESIC AGENTS.
AR028106A1 (en) FORMULATIONS OF POTASSIUM GLYPHOSATE
ITRM20000483A0 (en) STRUCTURED CLOTHING FOR THE PROTECTION OF THE MOTORCYCLIST.
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
BR9902086A (en) Pharmaceutical formulations.
CY1105390T1 (en) THERAPEUTIC MANAGEMENT OF PULMONARY HYPERTENSION
HN2001000027A (en) PURINA DERIVATIVES
HUP0401190A3 (en) Treatment of nail infections using no generating compositions
CU23148A3 (en) AZAPOLICICLIC COMPOUNDS CONDENSED WITH ARILO
MA26866A1 (en) ANTIBACTERIAL AGENTS CONSISTING OF 3-AMINOQUINAZOLINE-2,4-DIONES
BR0208154A (en) Cyclically guanosine 3 ', 5'-monophosphate phosphodiesterase inhibitors
BRPI0411900A (en) antiviral compounds and methods
HN2002000050A (en) PHARMACEUTICALLY ACTIVE COMPOUNDS
ITTO20010120A0 (en) PROCEDURE FOR THE MANUFACTURE OF A HOLLOW BODY CONSTITUTING A BICYCLE COMPONENT, IN PARTICULAR FOR THE MANUFACTURE OF THE BOX
IS6933A (en) Antiviral formulations
ITMI20000572A0 (en) LOCK FOR FRAMES WITH HIGH FLEXIBILITY OF USE
AU2003212936A8 (en) Peptide-dependent upregulation of telomerase expression
DE50213645D1 (en) vaporization
EE200300434A (en) Use of pharmaceutically active compounds
ITMI20012197A0 (en) SYSTEM TO AID THE OFFICIATING OF A FOOTBALL MATCH